Literature DB >> 26063484

MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.

Mayuko Kato1, Yusuke Goto1, Ryosuke Matsushita2, Akira Kurozumi1, Ichiro Fukumoto1, Rika Nishikawa1, Shinichi Sakamoto3, Hideki Enokida2, Masayuki Nakagawa2, Tomohiko Ichikawa3, Naohiko Seki1.   

Abstract

Our past studies of microRNA (miRNA) expression signatures of cancers including prostate cancer (PCa) revealed that microRNA-26a and microRNA-26b (miR-26a and miR-26b) were significantly downregulated in cancer tissues. In the present study, we found that restoration of miR-26a or miR-26b significantly inhibited PCa cell invasion. Gene expression data and in silico analysis showed that the gene encoding La-related protein 1 (LARP1) was a putative candidate of miR-26a and miR-26b regulation. Moreover, luciferase reporter assays revealed that LARP1 was a direct target of both miR-26a and miR-26b. Overexpression of LARP1 was observed in PCa clinical specimens and knockdown of LARP1 inhibited cancer cell migration. Therefore, LARP1 acted as an oncogene in PCa cells. Moreover, 'ribosome', 'RNA transport' and 'mTOR signaling pathway' were identified as LARP1-regulated pathways. Our present data suggested that loss of tumor-suppressive miR-26a and miR-26b enhanced cancer cell invasion in PCa through direct regulation of oncogenic LARP1. Elucidation of the molecular networks regulated by tumor-suppressive miRNAs will provide insights into the molecular mechanisms of PCa oncogenesis and metastasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26063484     DOI: 10.3892/ijo.2015.3043

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  36 in total

1.  Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.

Authors:  Mayuko Kato; Akira Kurozumi; Yusuke Goto; Ryosuke Matsushita; Atsushi Okato; Rika Nishikawa; Ichiro Fukumoto; Keiichi Koshizuka; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-06-09       Impact factor: 3.172

Review 2.  The emergence of noncoding RNAs as Heracles in autophagy.

Authors:  Jian Zhang; Peiyuan Wang; Lin Wan; Shouping Xu; Da Pang
Journal:  Autophagy       Date:  2017-04-25       Impact factor: 16.016

Review 3.  The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

4.  Downregulated microRNA-26a modulates prostate cancer cell proliferation and apoptosis by targeting COX-2.

Authors:  Jing Zhang; Jinghao Liang; Jianguo Huang
Journal:  Oncol Lett       Date:  2016-08-31       Impact factor: 2.967

5.  MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR.

Authors:  Long Zheng; Ye Kang; Lei Zhang; Wen Zou
Journal:  Cancer Biol Ther       Date:  2019-11-17       Impact factor: 4.742

6.  Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures.

Authors:  Fei Lu; Jingyan Gao; Yu Hou; Ke Cao; Yaoxiong Xia; Zhengting Chen; Hui Yu; Li Chang; Wenhui Li
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

7.  Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.

Authors:  Yasutaka Yamada; Rika Nishikawa; Mayuko Kato; Atsushi Okato; Takayuki Arai; Satoko Kojima; Kazuto Yamazaki; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2017-12-01       Impact factor: 3.172

8.  Paclitaxel resistance and the role of miRNAs in prostate cancer cell lines.

Authors:  Hale Samli; Murat Samli; Buse Vatansever; Sena Ardicli; Nazlihan Aztopal; Deniz Dincel; Ahmet Sahin; Faruk Balci
Journal:  World J Urol       Date:  2018-09-22       Impact factor: 4.226

Review 9.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

10.  lncRNA MALAT1/miR‑26a/26b/ST8SIA4 axis mediates cell invasion and migration in breast cancer cell lines.

Authors:  Nan Wang; Shengji Cao; Xiaoxi Wang; Lina Zhang; Hong Yuan; Xiaolu Ma
Journal:  Oncol Rep       Date:  2021-07-19       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.